Open Access

Observation of curative effects of Ex-PRESS and AGV implantation in the treatment of refractory glaucoma

  • Authors:
    • Wen Bo
    • Dongmei Dai
    • Fengxia Sun
  • View Affiliations

  • Published online on: March 20, 2018     https://doi.org/10.3892/etm.2018.5977
  • Pages: 4419-4425
  • Copyright: © Bo et al. This is an open access article distributed under the terms of Creative Commons Attribution License.

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )
Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )


Abstract

The curative effects of Ex-PRESS implantation and Ahmed glaucoma valve (AGV) implantation in the treatment of refractory glaucoma were compared. A total of 68 patients (76 eyes) with refractory glaucoma treated were randomly divided into Ex-PRESS group and AGV group. Results showed that the intraocular pressure IOP in both Ex-PRESS group and AGV group after operation was significantly decreased compared with that before operation (P<0.001). At 3, 6 and 9 months after operation, IOP in Ex-PRESS group was significantly lower than that in AGV group (P<0.05). At the end of follow-up, BCVA of patients in both groups after operation was slightly decreased compared with that before operation (P>0.05). There was no statistically significant difference in BCVA between the two groups of patients (P>0.05). Moreover, the corneal endothelial cell counts of patients in both groups after operation were obviously decreased compared with those before operation (P<0.05). The number of anti-glaucoma drugs applied was decreased from 3.53±0.86 to 0.55±0.60 in Ex-PRESS, and from 3.24±0.88 to 0.89±0.73 in AGV group. At the end of follow-up, the number of anti-glaucoma drugs applied in Ex-PRESS group was smaller than that in AGV group (P<0.05). There was no statistically significant difference in success rate of operation between the two groups at the end of follow-up (log-rank test; P>0.05). Finally, the incidence rates of postoperative complications and surgical intervention rates had no statistically significant differences between the two groups. Ex-PRESS implantation is a safe and effective treatment for refractory glaucoma, characterized by simple operation, small trauma and less pain, which has an equivalent curative effect to AGV implantation; but its control effect on IOP after operation is superior to that of AGV, and the number of anti-glaucoma drugs applied after operation is small.
View Figures
View References

Related Articles

Journal Cover

May-2018
Volume 15 Issue 5

Print ISSN: 1792-0981
Online ISSN:1792-1015

Sign up for eToc alerts

Recommend to Library

Copy and paste a formatted citation
x
Spandidos Publications style
Bo W, Dai D and Sun F: Observation of curative effects of Ex-PRESS and AGV implantation in the treatment of refractory glaucoma. Exp Ther Med 15: 4419-4425, 2018.
APA
Bo, W., Dai, D., & Sun, F. (2018). Observation of curative effects of Ex-PRESS and AGV implantation in the treatment of refractory glaucoma. Experimental and Therapeutic Medicine, 15, 4419-4425. https://doi.org/10.3892/etm.2018.5977
MLA
Bo, W., Dai, D., Sun, F."Observation of curative effects of Ex-PRESS and AGV implantation in the treatment of refractory glaucoma". Experimental and Therapeutic Medicine 15.5 (2018): 4419-4425.
Chicago
Bo, W., Dai, D., Sun, F."Observation of curative effects of Ex-PRESS and AGV implantation in the treatment of refractory glaucoma". Experimental and Therapeutic Medicine 15, no. 5 (2018): 4419-4425. https://doi.org/10.3892/etm.2018.5977